In Part 2 of our Life Sciences mini-series, Matt Harvison and Thomas Trammel shift focus from clinical trial cash burn to program and product-level cost forecasting.

They discuss how biotech organizations can model:

• Manufacturing costs by product

• Labor by shift and role

• Facility and overhead allocations

• Cost per unit trends

• What-if scenarios across headcount and volume

Learn how Workday Adaptive Planning enables life sciences teams to start simple and scale their forecasting sophistication over time, gaining visibility into margins before revenue even begins.